Primary HLH is a life-threatening genetic condition that often requires definitive treatment beyond symptom control. The advancement of hematopoietic stem cell transplantation (HSCT) has played a central role in shaping the Primary Haemophagocytic Lymphohistiocytosis Market. For many patients, transplantation remains the only curative therapy capable of correcting the underlying immune defect....
Italiano 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt